BME100 f2015:Group15 1030amL2

From OpenWetWare
Jump to navigationJump to search
Owwnotebook icon.png BME 100 Fall 2015 Home
Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3
Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6
Course Logistics For Instructors
Wiki Editing Help
BME494 Asu logo.png


Name: Paige Williams
Name: Sydney Spicer
Name: Esteban Medrano
Name: Elijah Olivas
Name: Vishal Giri
Name: Tofi Lautoa


Descriptive Statistics

Human trials
0mg 3.834
5mg 8.932
10mg 61.622
15mg 657.941

Standard Deviation
0mg 1.523010177
5mg 1.593931547
10mg 30.11069386
15mg 212.9429762

0mg 10
5mg 10
10mg 10
15mg 10

Standard Error
0mg 0.481618106
5mg 0.504045412
10mg 9.521837451
15mg 67.33848166

0mg 4.12
5mg 8.98
10mg 73.395
15mg 722.505

Rat trials


0 milligrams: 10.516
10 milligrams: 11.112

Standard Deviations

0 milligrams: 2.225551617 (units?)
10 milligrams: 7.402885924 (units?)

Standard Errors

0 milligrams: 0.99529694 (units?)
10 milligrams: 3.310671231 (units?)


Experiment 1

Rat Trials
rat trials results

Note: Error bars use standard deviation of data in this data set.

Experiment 2

Human Trials

Description of image


Experiment 1

  As seen in the data graphed above, as the dosage of LPS was increased from 0mg, 5mg, 10mg, and 15mg, the inflammotin levels in the blood of the rat rose consistently. When the data was put through an ANOVA test all of the data was found to be significant. 

Experiment 2

 When different groups of human subjects were given 0mg, 5mg, 10mg, and 15mg of LPS, the levels of inflammotin were then recorded. When this data was graphed it could be seen that as the dosage of LPS was raised, the inflammotin levels in the subjects rose as well. Before being graphed, the data was put through an ANOVA test and all of the data was found to be significant. The demonstrated error bars can be seen on the bar graph above and were calculated from the standard deviation of the data.  


  To answer the question of how LPS dosages affect inflammotin levels in the body, groups of rat and human test subjects were chosen by strict criteria so as to prevent sample bias as much as possible. Each dosage of LPS, 0mg, 5mg, 10mg, and 15mg, were each given to a different group of subjects. The inflammotin levels were then recorded and the data clearly shows that in both the rat and human test subjects, as the dosage of LPS was increased, the levels of inflammotin in the subjects increased. Both sets of data were put through ANOVA tests because the data was dealing with more than two test groups, and all of the data was found to be significant.